Abel Hall LLC
EBS icon

Abel Hall LLC’s Emergent Biosolutions EBS Stock Holding History

Abel Hall LLC’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$100K Buy
+15,141
New +$99.4K 0.02% 779
2026
Q2 		– Sell
-10,106
Closed -$83.9K – 1002
2026
Q1 		$83.9K Sell
10,106
-333
-3% -$3.45K 0.02% 705
2025
Q4 		$129K Buy
+10,439
New +$112K 0.03% 589

Other funds holding EBS

Values First Advisors
Values First Advisors Gray, Tennessee $213M AUM 20.51% 1-Year Est. Return
SummerHaven Investment Management
SummerHaven Investment Management Stamford, Connecticut $179M AUM 57.61% 1-Year Est. Return
James Investment Research
James Investment Research Alpha, Ohio $936M AUM 24.49% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
State of Wyoming
State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return
Oppenheimer Asset Management
Oppenheimer Asset Management New York $9.5B AUM 23.46% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Herold Advisors
Herold Advisors New York $512M AUM 21.14% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Abel Hall LLC's EBS Position: Q3 2026 in Review

Abel Hall LLC opened a new position in Emergent Biosolutions (EBS) in Q3 2026: 15,141 shares worth $100K. The stake represents 0.02% of the portfolio and ranks #779 among its holdings. This is a return to the name: Abel Hall LLC previously reported a position in EBS as recently as Q1 2026.

Abel Hall LLC first reported a position in EBS in Q4 2025 and has held it in 3 quarters since. The position peaked at $129K in Q4 2025. 30 funds tracked by Wall St. Rank hold EBS as of Q3 2026.

  • Abel Hall LLC held 15,141 shares of Emergent Biosolutions worth $100K as of Q3 2026.
  • Emergent Biosolutions was a new Abel Hall LLC position in Q3 2026.
  • Emergent Biosolutions made up 0.02% of Abel Hall LLC's portfolio in Q3 2026, its #779 holding.
  • Abel Hall LLC first reported a position in Emergent Biosolutions in Q4 2025 and has held it in 3 quarters since.
  • Abel Hall LLC's Emergent Biosolutions position peaked at $129K in Q4 2025.
  • 30 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.